Latest news | Page-4

Home

Clipping

Abes strengthens the speech of consolidation in the Brazilian IT sector

Tuesday, 06 July 2010 00:00

ABES´s president believes that the country would have more relevance in the global ICT market if the domestic industry had more medium and large IT companies.

China increases imports of manufactured goods from Brazil

Monday, 05 July 2010 12:12

After years of increase in the share of commodities, the share of semi-manufactured and manufactured goods imported by China from Brazil increased from 27.2% in 2008 to 28.3% in 2009, according to official figures.

IBM and Roche to conduct joint research on genomics

Friday, 02 July 2010 13:44

IBM and Roche Holding will conduct a research on genomics. The partnership intends to make affordable processes of genome sequencing for medical uses.

Mature drugs are "new" focus of laboratories

Friday, 02 July 2010 08:52

Traditional pharmaceutical companies, focused on research, start to invest more in medicines considered mature, ie, those which lose the patents but are good sales. Pfizer, Sanofi-Aventis and Merck (MSD) are investing in promoting this type of portfolio in Brazil.

See more Valor Econômico

Latin America plans to create a single telecom network

Thursday, 01 July 2010 15:29

Brazil, Chile, Peru, Argentina and Uruguay have met to discuss the establishment of a regional alliance with a goal of reducing costs in broadband services.

“This is no soccer match, only both sides must benefit”, says Timerman

Thursday, 01 July 2010 13:38

Argentina’s Foreign Affairs minister Héctor Timerman said that the pulp mill dispute with Uruguay over the can’t be seen as “a football match where one side wins and the other looses”, but rather as a situation where “the peoples of both countries benefit”.

With acquisition and partnerships, Aspen seeks to grow in Brazil

Wednesday, 30 June 2010 08:54

The pharmaceutical company Aspen, from South Africa, intends to expand its operations in Brazil through acquisitions and partnerships. The drugmaker, which acquired Cellofarma in the Brazilian market in 2008, acts in generic, OTC and licensing.

See more: Valor Econômico